SEI Investments
NXTM

SEI Investments’s NxStage Medical Inc. NXTM Stock Holding History

SEI Investments’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-114
Closed -$3K – 3610
2017
Q3 		$3K Sell
114
-1,098
-91% -$29.3K ﹤0.01% 2955
2017
Q2 		$30K Buy
1,212
+311
+35% +$7.7K ﹤0.01% 2360
2017
Q1 		$24K Buy
+901
New +$24.9K ﹤0.01% 2302

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments's NXTM Position: Q4 2017 in Review

SEI Investments sold out of NxStage Medical Inc. (NXTM) in Q4 2017, closing a stake of 114 shares — an estimated $3K sold.

SEI Investments first reported a position in NXTM in Q1 2017 and held it in 3 quarters. The position peaked at $30K in Q2 2017. 178 funds tracked by Wall St. Rank hold NXTM as of Q4 2017.

  • SEI Investments reported no remaining NxStage Medical Inc. position as of Q4 2017 after selling out during the quarter.
  • SEI Investments sold 114 NxStage Medical Inc. shares in Q4 2017, an estimated $3K.
  • SEI Investments first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 3 quarters.
  • SEI Investments's NxStage Medical Inc. position peaked at $30K in Q2 2017.
  • 178 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2017.

Based on SEI Investments's 13F filing for Q4 2017, filed 8 Feb 2018.